Carlsmed, Inc. (CARL): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$30.29M

Year ended 2025-12-31

-$38.26M

Trailing 12 months to 2026-06-30

2024-12-31 EBITDA (USD) 2025-12-31

Period ended	EBITDA	Change YoY	Source filing
2025-12-31	-$30.29M	n/m	2026-02-25, From 2025-01-01
2024-12-31	-$23.98M	n/a	2026-02-25, From 2024-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	EBITDA	Change YoY
Carlsmed, Inc. (CARL)	2025-12-31	-$30.29M	n/m
Apyx Medical Corp (APYX)	2025-12-31	-$5.79M	n/m
TriSalus Life Sciences, Inc. (TLSI)	2025-12-31	-$26.32M	n/m
SANUWAVE Health, Inc. (SNWV)	2025-12-31	$5.92M	+27.7%
SS Innovations International, Inc. (SSII)	2025-12-31	-$7.12M	n/m
KORU Medical Systems, Inc. (KRMD)	2025-12-31	-$2.16M	n/m
Interpace Biosciences, Inc. (IDXG)	2025-12-31	$4.51M	-46.4%
Retractable Technologies Inc (RVP)	2025-12-31	-$13.41M	n/m
Cytosorbents Corp (CTSO)	2025-12-31	-$13.52M	n/m

Compare CARL, APYX, TLSI, SNWV side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗